Senseonics Holdings, Inc. (SENS)

0.4160 +0.0138 (+3.43%) At close: 04:00PM EDT

Senseonics Holdings, Inc.

20451 Seneca Meadows Parkway
Germantown, MD 20876-7005
United States
301 515 7260
https://www.senseonics.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 132

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Timothy T. Goodnow Ph.D.	President, CEO & Director	1.28M	N/A	1962
Mr. Kenneth L. Horton	General Counsel & Corporate Development Advisor	737.28k	N/A	1967

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Senseonics Holdings, Inc., a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

Corporate governance

Senseonics Holdings, Inc.’s ISS governance QualityScore as of 1 April 2024 is 10. The pillar scores are Audit: 8; Board: 8; Shareholder rights: 8; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.